CD4 and cancer: CCL11 gene expression correlations were also modest in TCGA prostate and ovarian tumors but were much weaker in endometrial tumors and because our criteria for the top five genes were particularly stringent, requiring correlations with Spearman’s ρ > 0.5 for at least one of CD4, CD8A, CD11B and CD45 in all four cancer types, CCL11 was not among our top five genes.